CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 69 filers reported holding CABALETTA BIO INC in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,718,337 | +17.9% | 3,266,645 | 0.0% | 0.11% | +22.8% |
| Q2 2023 | $42,172,387 | +100.6% | 3,266,645 | +28.5% | 0.09% | +95.7% |
| Q1 2023 | $21,019,404 | -10.6% | 2,541,645 | 0.0% | 0.05% | -16.1% |
| Q4 2022 | $23,510,216 | +1323.1% | 2,541,645 | 0.0% | 0.06% | +1300.0% |
| Q3 2022 | $1,652,000 | -38.7% | 2,541,645 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $2,694,000 | -47.8% | 2,541,645 | 0.0% | 0.01% | -40.0% |
| Q1 2022 | $5,160,000 | -46.4% | 2,541,645 | 0.0% | 0.01% | -41.2% |
| Q4 2021 | $9,633,000 | -74.0% | 2,541,645 | -16.4% | 0.02% | -76.7% |
| Q3 2021 | $36,986,000 | +41.4% | 3,041,645 | 0.0% | 0.07% | +43.1% |
| Q2 2021 | $26,158,000 | -22.5% | 3,041,645 | 0.0% | 0.05% | -26.1% |
| Q1 2021 | $33,762,000 | -14.9% | 3,041,645 | -4.4% | 0.07% | -20.7% |
| Q4 2020 | $39,696,000 | +7.6% | 3,180,805 | -6.6% | 0.09% | -5.4% |
| Q3 2020 | $36,908,000 | -7.1% | 3,404,760 | -4.5% | 0.09% | -9.8% |
| Q2 2020 | $39,714,000 | +50.9% | 3,565,009 | -1.1% | 0.10% | +29.1% |
| Q1 2020 | $26,315,000 | -49.7% | 3,604,760 | -3.7% | 0.08% | -38.3% |
| Q4 2019 | $52,275,000 | – | 3,741,926 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |